Abeona Therapeutics Inc
ABEO
NASDAQ
Biotechnology
$5.99
USD
-0.36 (-5.67%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $363.91M
Volume 5.4M
Price Target
$20.00 – $20.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $20.00 and a min estimate of $20.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$20.00
Unchanged vs prior
Implied Upside
+233.9%
Unchanged vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Raghuram Selvaraju | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TLSI
TriSalus Life Sciences Inc
$5.27
▼ -6.4%
AGEN
Agenus Inc
$7.32
▲ +4.6%
STRO
Sutro Biopharma Inc
$20.48
▼ -3.9%
IMRX
Immuneering Corp
$5.06
▼ -2.7%
GALT
Galectin Therapeutics Inc
$3.44
▼ -2.5%
LYEL
Lyell Immunopharma Inc
$13.95
▲ +1.5%
IKT
Inhibikase Therapeutics Inc
$2.41
▲ 0.0%
SABS
SAB Biotherapeutics Inc
$3.70
▼ -1.3%
IPSC
Century Therapeutics Inc
$1.92
▼ -0.5%